SUMMARY Blood films from 41 cases of coeliac disease complicated by malignancy were examined and evidence of hyposplenism found in 12 cases (29%). This is similar to the proportion of adult coeliacs without malignancy who have hypoplenism and it is concluded that impaired splenic function is not associated with the development of malignancy in coeliac disease.
Malignancy is a well-recognised complication of coeliac disease,' 2 the characteristic tumour being small intestinal lymphoma,3 but increased susceptibility to other malignancies, particularly of the gastrointestinal tract, is also recognised. 4 Why patients with coeliac disease should develop malignancy is unknown. Villous atrophy may be a pre-malig nant condition, chronic nutritional deficiency or uptake of a carcinogen from the gastrointestinal tract may lead to malignant change, or there may be inadequate immune surveillance in the coeliac patient.
Immune abnormalities occur frequently in coeliac disease. Autoantibodies and autoimmune disease are common,6 and atrophy of the lymphoreticular system, in particular the spleen, is well recognised. 7 The mechanism of splenic atrophy remains unknown. It may be a complication of chronic folate deficiency, or may be the result of excessive loss of lymphocytes through the damaged gastrointestinal tract, and there are animal models to support both these hypotheses.8 9 Alternatively, splenic atrophy may occur as a result of the same immunological damage that causes the villous atrophy.
It has been suggested that splenic atrophy and malignant disease may be related7 -for example, as well as causing splenic atrophy, loss of lymphocytes through the gastrointestinal tract may lead to loss of cell-mediated immunity and immune surveillance and the development of neoplasia. In support of this, lymphoma of the small bowel has been associated with the lymphocyte depletion occurring in intestinal lymphangiectasia. ' Twelve patients (29%) were considered to have blood film changes diagnostic of hyposplenism. Of these, seven had all four blood film abnormalities, three had three, and two had two only. Two patients had target cells and giant platelets, which might not have been due to hyposplenism: patient 3 had polycythaemia rubra vera, and patient 8 a regenerating hypochromic anaemia, and these were considered not to have hyposplenism.
If the group with hyposplenism is compared with the remainder, they are seen to be older at the time of diagnosis of coeliac disease (57 v 51 years) and at the time of blood film examination (63 v 57 years), but these differences were not statistically 1 
Discussion
Splenic size and function has been measured in coeliac disease using a variety of methods of differing sensitivity. These methods include measuring the rate of clearance of heat-damaged red cells from the circulation, a measure of reticuloendothelial function,13 visualisation of the spleen by scintography14 when the volume of functioning splentic tissue can be calculated, and evidence of impaired splenic function on the blood film. 15 Splenic function in coeliac disease probably declines gradually until there may be a slightly reduced splenic volume, with slightly delayed red cell clearance, although the spleen still retains enough function to clear inclusions such as Howell-Jolly bodies from red cells. It follows that the reported incidence of hyposplenism depends upon the method of detection, and upon the age of the patient, particularly the age at which a gluten-free diet was instituted.
Thus Pettit et al16 found in their study of patients with dermatitis herpetiformis associated with small bowel biopsy abnormalities that seven of 24 patients (mean age 46 years) had evidence on blood film of hyposplenism, eight had delayed red cell clearance, and that the average spleen size was well below the normal mean, but still within the normal range.
Marsh and Stewart17 found that five of 18 patients (mean age 51 years) with adult coeliac disease had evidence on blood film of hyposplenism, and that these five patients had marked delay in clearance of heat-damaged red cells. Nine other patients had slightly delayed clearance, but normal blood films. It is possible that minor changes related to hyposplenism which may be overlooked in blood films could be detected using more sensitive techniques. The nature of this study made red cell clearance measurements or reproducible spleen scanning impossible, so that the figure of 12 hyposplenic patients may be an underestimate, but is unlikely to be an overestimate.
Coeliac disease and hyposplenism are not particularly associated with malignancy in this series and there was no relationship between hyposplenism and the type of malignancy. This suggests that the patient with coeliac disease and hyposplenism is no more at risk of developing malignancy in general or lymphoma in particular than if his splenic function were normal.
We are greatly indebted to the numerous clinicians throughout the country who have reported patients for inclusion in the National Study of Coeliac Disease and Malignancy, set up after a meeting at the Clinical Research Centre, Harrow, in November 1978, and, in particular, to those who have sent blood samples from patients under their care.
